צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Altamira Therapeutics Ltd. (CYTO)

The restructuring of therapeutic platforms at Altamira Therapeutics (CYTO) led to targeted management changes, which triggered a spike in the YoY dynamics of commercial revenue for the LTM. Meanwhile, 0.00 represents the current level of this metric. The absence of recurring revenue makes finances dependent on investments, although the business's research status guarantees macro-stability and complete independence from consumer cycles.
altamiratherapeutics.com (CYTO) - פילוחי מדדים ודוחות פיננסיים

To minimize investment risks, it is essential to distinguish short-term spikes from a sustainable trend, which is particularly critical when evaluating the pharmaceutical logistics efficiency of Altamira Therapeutics (CYTO). By analyzing the LTM gross revenue dynamics, an investor can observe the change in sales volume over a rolling year, allowing for an assessment of the company's real commercial growth rate and preventing overpayment for the asset during periods of anomalous peaks.